Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsNavneeteducation

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to
    • Focus on midcap pharma space: Gautam Trivedi

      Focus on midcap pharma space: Gautam Trivedi

      Gautam Trivedi, MD & CEO of Religare Capital Markets is of the view that one may focus on midcap pharma space.

    • Buy Natco Pharma for long term: Rahul Arora

      Buy Natco Pharma for long term: Rahul Arora

      Rahul Arora, CEO at Nirmal Bang Institutional Equities recommends buying Natco Pharma with a long term view.

    • Here are top 10 stocks to keep an eye on January 21

      Here are top 10 stocks to keep an eye on January 21

      Here are top 10 stocks to keep an eye on January 21 - HDFC, HDFC Bank, ICICI Bank, Mahindra & Mahindra Financials, Suzlon Energy, Tata Motors, Natco Pharma, Crompton Greaves, Excel Crop Care & Praj Industries.

    • Buy Natco Pharma: Rahul Arora

      Buy Natco Pharma: Rahul Arora

      Rahul Arora, CEO at Nirmal Bang Institutional Equities is of the view that one can buy Natco Pharma at Rs 1500.

    • Pharma space to outperform, says Jaideep Goswami

      Pharma space to outperform, says Jaideep Goswami

      According to Jaideep Goswami, Head of Equity at ICICI Securities, pharma sector being export oriented sector will continue to outperform in at least first few months of the year.

    • Pick Cipla, Dr Reddys Labs: Sriram Rathi

      Pick Cipla, Dr Reddys Labs: Sriram Rathi

      Sriram Rathi, pharma analyst at Anand Rathi is of the view that one may pick Cipla and Dr Reddys Laboratories from largecap pharma space.

    • Buy Natco Pharma, Cox & Kings; sell Jubilant Food: Diwan

      Buy Natco Pharma, Cox & Kings; sell Jubilant Food: Diwan

      Prakash Diwan of Asit C Mehta recommends going long on Natco Pharma with a target of Rs 829 and Cox & Kings with a target of Rs 103.50.

    • Bull's Eye: Natco Pharma, Arvind, Aurobindo, Cox & Kings

      Bull's Eye: Natco Pharma, Arvind, Aurobindo, Cox & Kings

      Kunal Bothra of LKP Shares advises buying Finolex Cables for a target price of Rs 78 and Indiabulls Housing Finance for a target price of Rs 228.

    • Bull's Eye: Buy Amara Raja, Natco Pharma; short Siemens

      Bull's Eye: Buy Amara Raja, Natco Pharma; short Siemens

      Rajesh Agarwal of Eastern Financiers advised buying Natco Pharma with a target price of Rs 635 and Dhanlaxmi Bank with a target price of Rs 31.

    • Trading Calls: Brokerages suggest buying 6 stocks today

      Trading Calls: Brokerages suggest buying 6 stocks today

      Brokerages are bullish on Natco Pharma, SAIL, Reliance Capital, RIL and ICICI Bank.

    • Exit Natco Pharma: Sukhani

      Exit Natco Pharma: Sukhani

      Sudarshan Sukhani, s2analytics.com is of the view that one should exit Natco Pharma.

    • Year 2013: 11 stocks that can give you handsome returns

      Year 2013: 11 stocks that can give you handsome returns

      Moneycontrol.com got AK Prabhakar, senior VP-equity research, Anand Rathi to answer the stock queries you sent us on our Facebook page as part of KYI (Know Your Investment). Check out his comments.

    • Diwan upbeat on RIL, Infosys, Natco Pharma

      Diwan upbeat on RIL, Infosys, Natco Pharma

      Prakash Diwan, Prakash Diwan's Wealth Circle is upbeat on RIL, Infosys and Natco Pharma.

    • Bull's Eye: Buy Titan, Bajaj Finserv, Tata Coffee

      Bull's Eye: Buy Titan, Bajaj Finserv, Tata Coffee

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Exit from Natco Pharma, says Aashish Tater

      Exit from Natco Pharma, says Aashish Tater

      Aashish Tater, Head of Research, Fort Share Broking advice traders to exit from Natco Pharma.

    • Bull's Eye: Short Kingfisher, ICICI Bank; buys Welspun Corp

      Bull's Eye: Short Kingfisher, ICICI Bank; buys Welspun Corp

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347